BACKGROUND: Racial and ethnic minority groups in the United States experience a disproportionate burden of COVID-19 deaths. OBJECTIVE: To evaluate whether outcome differences between Hispanic and non-Hispanic COVID-19 hospitalized patients exist and, if so, to identify the main malleable contributing factors. DESIGN, SETTING, PARTICIPANTS: Retrospective, cross-sectional, observational study of 6097 adult COVID-19 patients hospitalized within a single large healthcare system from March to November 2020. EXPOSURES: Self-reported ethnicity and primary language. MAIN OUTCOMES AND MEASURES: Clinical outcomes included intensive care unit (ICU) utilization and in-hospital death. We used age-adjusted odds ratios (OR) and multivariable analysis to evaluate the associations between ethnicity/language groups and outcomes. RESULTS: 32.1% of patients were Hispanic, 38.6% of whom reported a non-English primary language. Hispanic patients were less likely to be insured, have a primary care provider, and have accessed the healthcare system prior to the COVID-19 admission. After adjusting for age, Hispanic inpatients experienced higher ICU utilization (non-English-speaking: OR, 1.75; 95% CI, 1.47-2.08; English-speaking: OR, 1.13; 95% CI, 0.95-1.33) and higher mortality (non-English-speaking: OR, 1.43; 95% CI, 1.10-1.86; English-speaking: OR, 1.53; 95% CI, 1.19-1.98) compared to non-Hispanic inpatients. There were no observed treatment disparities among ethnic groups. After adjusting for age, Hispanic inpatients had elevated disease severity at admission (non-English-speaking: OR, 2.27; 95% CI, 1.89-2.72; English-speaking: OR, 1.33; 95% CI, 1.10- 1.61). In multivariable analysis, the associations between ethnicity/language and clinical outcomes decreased after considering baseline disease severity (P < .001). CONCLUSION: The associations between ethnicity and clinical outcomes can be explained by elevated disease severity at admission and limited access to healthcare for Hispanic patients, especially non-English-speaking Hispanics.
BACKGROUND: Racial and ethnic minority groups in the United States experience a disproportionate burden of COVID-19 deaths. OBJECTIVE: To evaluate whether outcome differences between Hispanic and non-Hispanic COVID-19 hospitalized patients exist and, if so, to identify the main malleable contributing factors. DESIGN, SETTING, PARTICIPANTS: Retrospective, cross-sectional, observational study of 6097 adult COVID-19 patients hospitalized within a single large healthcare system from March to November 2020. EXPOSURES: Self-reported ethnicity and primary language. MAIN OUTCOMES AND MEASURES: Clinical outcomes included intensive care unit (ICU) utilization and in-hospital death. We used age-adjusted odds ratios (OR) and multivariable analysis to evaluate the associations between ethnicity/language groups and outcomes. RESULTS: 32.1% of patients were Hispanic, 38.6% of whom reported a non-English primary language. Hispanic patients were less likely to be insured, have a primary care provider, and have accessed the healthcare system prior to the COVID-19 admission. After adjusting for age, Hispanic inpatients experienced higher ICU utilization (non-English-speaking: OR, 1.75; 95% CI, 1.47-2.08; English-speaking: OR, 1.13; 95% CI, 0.95-1.33) and higher mortality (non-English-speaking: OR, 1.43; 95% CI, 1.10-1.86; English-speaking: OR, 1.53; 95% CI, 1.19-1.98) compared to non-Hispanic inpatients. There were no observed treatment disparities among ethnic groups. After adjusting for age, Hispanic inpatients had elevated disease severity at admission (non-English-speaking: OR, 2.27; 95% CI, 1.89-2.72; English-speaking: OR, 1.33; 95% CI, 1.10- 1.61). In multivariable analysis, the associations between ethnicity/language and clinical outcomes decreased after considering baseline disease severity (P < .001). CONCLUSION: The associations between ethnicity and clinical outcomes can be explained by elevated disease severity at admission and limited access to healthcare for Hispanic patients, especially non-English-speaking Hispanics.
Authors: Perrine Janiaud; Cathrine Axfors; Andreas M Schmitt; Viktoria Gloy; Fahim Ebrahimi; Matthias Hepprich; Emily R Smith; Noah A Haber; Nina Khanna; David Moher; Steven N Goodman; John P A Ioannidis; Lars G Hemkens Journal: JAMA Date: 2021-03-23 Impact factor: 56.272
Authors: Zachary G Jacobs; Priya A Prasad; Margaret C Fang; Yumiko Abe-Jones; Kirsten N Kangelaris Journal: J Hosp Med Date: 2019-11-20 Impact factor: 2.960
Authors: Benjamin D Renelus; Neil C Khoury; Karthik Chandrasekaran; Ezana Bekele; William M Briggs; Alexander Ivanov; Smruti R Mohanty; Daniel S Jamorabo Journal: J Racial Ethn Health Disparities Date: 2020-09-18
Authors: Chengzhen L Dai; Sergey A Kornilov; Ryan T Roper; Hannah Cohen-Cline; Kathleen Jade; Brett Smith; James R Heath; George Diaz; Jason D Goldman; Andrew T Magis; Jennifer J Hadlock Journal: Clin Infect Dis Date: 2021-12-16 Impact factor: 9.079
Authors: Shirley Sze; Daniel Pan; Clareece R Nevill; Laura J Gray; Christopher A Martin; Joshua Nazareth; Jatinder S Minhas; Pip Divall; Kamlesh Khunti; Keith R Abrams; Laura B Nellums; Manish Pareek Journal: EClinicalMedicine Date: 2020-11-12
Authors: Orestis A Panagiotou; Cyrus M Kosar; Elizabeth M White; Leonidas E Bantis; Xiaofei Yang; Christopher M Santostefano; Richard A Feifer; Carolyn Blackman; James L Rudolph; Stefan Gravenstein; Vincent Mor Journal: JAMA Intern Med Date: 2021-04-01 Impact factor: 21.873
Authors: Shruti Gupta; Wei Wang; Salim S Hayek; Lili Chan; Kusum S Mathews; Michal L Melamed; Samantha K Brenner; Amanda Leonberg-Yoo; Edward J Schenck; Jared Radbel; Jochen Reiser; Anip Bansal; Anand Srivastava; Yan Zhou; Diana Finkel; Adam Green; Mary Mallappallil; Anthony J Faugno; Jingjing Zhang; Juan Carlos Q Velez; Shahzad Shaefi; Chirag R Parikh; David M Charytan; Ambarish M Athavale; Allon N Friedman; Roberta E Redfern; Samuel A P Short; Simon Correa; Kapil K Pokharel; Andrew J Admon; John P Donnelly; Hayley B Gershengorn; David J Douin; Matthew W Semler; Miguel A Hernán; David E Leaf Journal: JAMA Intern Med Date: 2021-01-01 Impact factor: 21.873
Authors: Fatima Rodriguez; Nicole Solomon; James A de Lemos; Sandeep R Das; David A Morrow; Steven M Bradley; Mitchell S V Elkind; Joseph H Williams; DaJuanicia Holmes; Roland A Matsouaka; Divya Gupta; Ty J Gluckman; Marwah Abdalla; Michelle A Albert; Clyde W Yancy; Tracy Y Wang Journal: Circulation Date: 2020-11-17 Impact factor: 29.690
Authors: Mohammad A Al-Mamun; Jacob Strock; Yushuf Sharker; Khaled Shawwa; Rebecca Schmidt; Douglas Slain; Ankit Sakhuja; Todd N Brothers Journal: J Clin Med Date: 2022-08-11 Impact factor: 4.964